Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Characteristics of Patients With Thymoma in Chulalongkorn Hospital

This study has been completed.
Sponsor:
Information provided by:
Chulalongkorn University
ClinicalTrials.gov Identifier:
NCT01123590
First received: May 12, 2010
Last updated: November 21, 2010
Last verified: November 2010

May 12, 2010
November 21, 2010
November 2009
April 2010   (final data collection date for primary outcome measure)
Thymoma staging and clinical manifestations [ Time Frame: 5 years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01123590 on ClinicalTrials.gov Archive Site
Associated diseases and laboratory findings Immunological data [ Time Frame: 4 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Characteristics of Patients With Thymoma in Chulalongkorn Hospital
Characteristics of Patients With Thymoma Undergone Thymectomy in Chulalongkorn Hospital Between 2003-2007

The purpose of this study is to study characteristics of patients with thymoma in Chulalongkorn hospital between 2003-2007.

To study characteristics of patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007 in terms of clinical manifestations, associated diseases, and laboratory findings.

Observational
Observational Model: Case Control
Time Perspective: Retrospective
Not Provided
Retention:   Samples Without DNA
Description:

PBMC

Non-Probability Sample

Patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007

  • Thymoma Staging
  • Clinical Presentations
  • Associated Disorders
  • Laboratory Findings
Not Provided
  • Thymoma
    Patients with thymoma
  • Control
    Normal controls
Thongprayoon C, Tantrachoti P, Phatharacharukul P, Buranapraditkun S, Klaewsongkram J. Associated immunological disorders and cellular immune dysfunction in thymoma: a study of 87 cases from Thailand. Arch Immunol Ther Exp (Warsz). 2013 Feb;61(1):85-93. doi: 10.1007/s00005-012-0207-9. Epub 2012 Dec 11.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
October 2010
April 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with histocytological proved thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007

Exclusion Criteria:

  • None
Both
Not Provided
Yes
Contact information is only displayed when the study is recruiting subjects
Thailand
 
NCT01123590
Chula-ARC 003/09
Yes
Jettanong Klaewsongkram, Chulalongkorn University
Chulalongkorn University
Not Provided
Principal Investigator: Jettanong Klaewsongkram, MD Chulalongkorn University
Chulalongkorn University
November 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP